Home > Financial Ratios > BROOKS LABORATORIES

BROOKS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results

BROOKS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 39.52115.92-94.85-1,170.52-

What is the latest Core EBITDA Growth ratio of BROOKS LABORATORIES ?

The latest Core EBITDA Growth ratio of BROOKS LABORATORIES is 39.52 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202539.52
Mar2024115.92
Mar2023-94.85
Mar2022-1,170.52
Mar2021-

How is Core EBITDA Growth of BROOKS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 39.52
-65.91
Mar2024 115.92
Positive
Mar2023 -94.85
Negative
Mar2022 -1170.52
0
Mar2021 0 -

Other Financial Ratios of BROOKS LABORATORIES


Compare Core EBITDA Growth ratio of peers of BROOKS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BROOKS LABORATORIES ₹258.9 Cr -7% -17.1% -45.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,494.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹170,514.0 Cr -0.9% -1.4% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,044.0 Cr 2% 2.4% 11.2% Stock Analytics
CIPLA ₹121,574.0 Cr -0.8% -1.2% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,919.0 Cr -0.8% 1.7% -5.6% Stock Analytics


BROOKS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

-7%

-17.1%

-45.6%

SENSEX

0.7%

0.5%

9%


You may also like the below Video Courses